OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

2005 Individual Investigator Grant Recipient – Lawrence Kane

Lawrence Kane, Ph.D.
University of Pittsburgh
Characterizing Molecular Defects in Ovarian Cancer

Project Summary

Biochemical pathways that control cell growth and survival are commonly altered in cancer. Understanding the particular defects in each type of cancer could lead to the development of better and more specific anti-cancer therapeutics. One example of a faulty molecule in ovarian cancer is a protein known as Akt. This project aims to understand how Akt modulates another pathway in ovarian cancer cells called NF-kappaB and how they both affect the growth of the cells. Findings should provide a better understanding of the biology of the disease and new targets for treatments.